These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Okwusidi JI, Anvari N, Kulczycky M, Blajchman MA, Buchanan MR, Ofosu FA. J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790 [Abstract] [Full Text] [Related]
4. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis). Peters RJ, Spickler W, Théroux P, White H, Gibson M, Molhoek PG, Anderson HV, Weitz JI, Hirsh J, Weaver WD. Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461 [Abstract] [Full Text] [Related]
5. Enhancement of heparin cofactor II anticoagulant activity. Bauman SJ, Church FC. J Biol Chem; 1999 Dec 03; 274(49):34556-65. PubMed ID: 10574918 [Abstract] [Full Text] [Related]
6. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin. Liaw PC, Becker DL, Stafford AR, Fredenburgh JC, Weitz JI. J Biol Chem; 2001 Jun 15; 276(24):20959-65. PubMed ID: 11294849 [Abstract] [Full Text] [Related]
7. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Nagase H, Enjyoji K, Minamiguchi K, Kitazato KT, Kitazato K, Saito H, Kato H. Blood; 1995 Mar 15; 85(6):1527-34. PubMed ID: 7888673 [Abstract] [Full Text] [Related]
10. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA. Nouv Rev Fr Hematol (1978); 1988 Mar 15; 30(3):155-60. PubMed ID: 2971155 [Abstract] [Full Text] [Related]
11. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin. Holland CA, Henry AT, Whinna HC, Church FC. FEBS Lett; 2000 Nov 03; 484(2):87-91. PubMed ID: 11068038 [Abstract] [Full Text] [Related]
12. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA. Blood; 1984 Sep 03; 64(3):742-7. PubMed ID: 6235872 [Abstract] [Full Text] [Related]
14. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques. Demir M, Iqbal O, Untch B, Hoppensteadt DA, Gaikwad BS, Fareed J. Clin Appl Thromb Hemost; 2001 Jan 03; 7(1):38-43. PubMed ID: 11190903 [Abstract] [Full Text] [Related]
20. Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: anticoagulant activity and mechanism of action. Ben Mansour M, Dhahri M, Hassine M, Ajzenberg N, Venisse L, Ollivier V, Chaubet F, Jandrot-Perrus M, Maaroufi RM. Comp Biochem Physiol B Biochem Mol Biol; 2010 Jul 03; 156(3):206-15. PubMed ID: 20363356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]